Contrary to common misconceptions, R&D does not take place solely in laboratories or traditional R&D departments.
Companies from a variety of industries can take advantage of the tremendous Research and Development tax incentives.
R&D Tax Savers' experts have helped numerous clients from different segments benefit from R&D tax credits. Your company can be next!
Here are some examples of industry specific practices that are likely to qualify under the Internal Revenue Code's definition of R&D:
Aerospace and Defense companies engaged in any of the following activities are likely to be eligible for R&D tax credits:
The common misconception about the Research and Development (R&D) tax credit is solely for traditional white lab-coat activities and manufacturers. Recent legislation has broadened the industries and companies that qualify for the credit. Common R&D eligible activities include:
Despite the tremendous tax incentive, most eligible companies (more than 65%) are unaware or fail to take full advantage of the generous R&D tax credit. Companies, large and small, in a broad range of industries, often overlook research expenses in their field, due to misconceptions about common activities that qualify. Our experts understand the R&D tax credit is not limited to traditional white lab-coat activities or manufacturing, and can use our streamlined process to extract the full potential of your company's R&D. If your company is involved in any type of research, development, or improvement of new or existing products, processes, formulations, or software your company likely qualifies, and R&D Tax Savers can help you quantify and defend your R&D tax credit.
Engineering firms engaged in any of the following activities are likely to be eligible for R&D tax credits:
Biotechnology companies engaged in any of the following activities are likely to be eligible for R&D tax credits:
Since its adoption in 1981, the R&D tax credit has been a significant tool to promote domestic innovation and maximize the
bottom line of companies across a wide spectrum of industries. Over the past 30 years, the credit has evolved constantly through
legislation and treasury regulations which have developed into 3 pronouced phases, Adoption, Redefinition, and
Examination. Our expertise and understanding of the history of the R&D tax credit allow us a better approach and refined process
in order to capture the maximum savings and required documentation for your company.
In extreme situations, audit appeals can result in cases filed with the U.S. Tax Court.
Through this process, the court further interprets and clarifies the rules and regulations regarding the R&D tax credit. Specific rulings
can effectively change how the tax credit is handled by companies and the IRS. Therefore, we must stay up to date on the issues and
resolutions in R&D case law. By understanding the details and requirements that the IRS emphasizes, we can create simpler yet stronger
claims and maximize your savings.
As part of our own research and development, we are continuously following the latest R&D tax credit developments in legislation
and case law, in order to provide our clients with the most comprehensive information through our published articles, online encyclopedia,
and blog. Our experts understand the importance of knowledge, collaboration, and most importantly sharing so we strive to get the most
up to date information and convey it to our clients in a simpler more comprehensible way.
Electronics companies engaged in any of the following activities are likely to be eligible for R&D tax credits:
Generic drugs companies engaged in any of the following activities are likely to be eligible for R&D tax credits:
Information Technology and Communication companies engaged in any of the following activities are likely to be eligible for R&D tax credits:
Manufacturing companies engaged in any of the following activities are likely to be eligible for R&D tax credits:
Advanced Materials companies working with metals, polymers (thermoplastics and thermosets), ceramics, glasses, or composites are likely to qualify for R&D tax credits when engaged in the following activities:
Pharmaceutical companies engaged in any of the following activities are likely to be eligible for R&D tax credits:
The common misconception about the Research and Development (R&D) tax credit is solely for traditional white lab-coat activities and manufacturers. Recent legislation has broadened the industries and companies that qualify for the credit. Common R&D eligible activities include:
